Who Buys Propranolol from India — 363 Importers Behind a $58.1M Market
India's propranolol import market is served by 363 active buyers who collectively imported $58.1M across 3,988 shipments. MILPHARM LIMITED, (UNITED KINGDOM) leads with a 3.0% market share, followed by XXNEAXXPHAXXACEXXICAXX LXX (NXX and AMNEAL PHARMACEUTICALS LLC NJ. The top 5 buyers together control 9.3% of total import value, reflecting a moderately competitive buyer landscape.
Propranolol buyer data — 363 importers · $58.1M market · 3,988 shipmentsTransData Nexus · Indian Customs Data
Top Propranolol Importers — Ranked by Import Value
MILPHARM LIMITED, (UNITED KINGDOM) is the leading propranolol importer from India, holding a 3.0% share of the $58.1M market across 3,988 shipments from 363 buyers. The top 5 buyers — MILPHARM LIMITED, (UNITED KINGDOM), XXNEAXXPHAXXACEXXICAXX LXX (NXX (UNITED STATES), AMNEAL PHARMACEUTICALS LLC NJ (UNITED STATES), APOTEX PTY LTD (AUSTRALIA), ACTAVIS LABORATORIES FL, INC. (UNITED STATES) — collectively control 9.3% of total import value.
Top Propranolol Buyers & Importers
Ranked by import value · 363 active buyers · Indian Customs (DGFT) data
Apr 2026
Top Propranolol Buyers & Importers — Ranked by Import Value. 363 active buyers with import value, shipments, country and supplier data compiled from Indian Customs records by TransData Nexus.
Which companies are buying Propranolol — and from which countries?
Flow of Propranolol exports from India: each country's share and the named importers behind the numbers
Propranolol — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Top 5 importing countries account for 92.8% of global Propranolol imports — led by Australia (43.9%) with a total trade value of $58.1M across 3,988 shipments from India.
Market Analysis: Top Importing Countries & Their Importers
1Australia
Australia emerges as the first largest importing country, achieving a total trade value of $25.5M through 14 shipments. This represents a market share of 43.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Australia has a diverse importer base, with their top importers including:
• APOTEX PTY LTD - $734.5K (2.9% of country's total business)
Key Insight: Australia demonstrates strong market positioning with an average shipment value of $1.8M, indicating premium pricing strategy compared to the market average of $14.6K.
Australia is a key market for Propranolol imports, representing 43.9% of total trade value.
Primary Market
Secondary Market
2United States
United States emerges as the second largest importing country, achieving a total trade value of $21.7M through 55 shipments. This represents a market share of 37.5% of the total market activity, demonstrating their significant presence in the industry.
The importation of Propranolol from India involves various buyer segments, each with distinct purchasing behaviors:
Distributors: Entities like MILPHARM LIMITED (United Kingdom) and APOTEX PTY LTD (Australia) function as intermediaries, procuring large quantities to supply to pharmacies and healthcare providers. Their purchasing patterns are characterized by bulk orders to maintain consistent supply chains.
Contract Manufacturers: Companies such as AMNEAL PHARMACEUTICALS LLC NJ (United States) and ACTAVIS LABORATORIES FL, INC. (United States) import Propranolol as an active pharmaceutical ingredient (API) for formulation into finished products. Their procurement is driven by production schedules and market demand forecasts.
Re-exporters: Firms like ACCORD HEALTHCARE, SLU (Spain) and BROCACEF NL : HUB (Netherlands) import Propranolol for redistribution to other markets. Their purchasing behavior is influenced by global demand trends and regulatory considerations in target countries.
Government Procurement Agencies: While not explicitly listed among the top buyers, entities such as national health services or government-affiliated organizations may engage in tender-based purchasing to supply public healthcare facilities. Their procurement processes are typically guided by budget allocations and public health priorities.
Import Registration Process: Propranolol must be listed on the Australian Register of Therapeutic Goods (ARTG). Importers must submit an application to the TGA, including evidence of product quality, safety, and efficacy.
Estimated Timeline: The registration process typically takes 6 to 12 months.
Import Tariff/Duty: Pharmaceutical products under HS Code 30049074 are generally duty-free, but Goods and Services Tax (GST) may apply.
United States:
Regulatory Authority: U.S. Food and Drug Administration (FDA).
The demand for Propranolol in importing countries is influenced by several factors:
Disease Prevalence: Propranolol is primarily used to manage cardiovascular conditions such as hypertension and arrhythmias. The global rise in cardiovascular diseases, attributed to aging populations and lifestyle changes, has increased the need for effective treatments.
Government Healthcare Programs: Many countries have implemented programs to enhance access to essential medicines. For instance, the World Health Organization (WHO) emphasizes the importance of including essential medicines like Propranolol in national formularies to ensure availability and affordability.
Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased procurement of essential medicines. Countries expanding their healthcare coverage are likely to boost demand for cost-effective treatments like Propranolol.
WHO Essential Medicines List Procurement: Propranolol's inclusion in the WHO Essential Medicines List underscores its importance in treating priority health conditions. This designation encourages countries to prioritize its procurement and distribution.
Common Questions — Propranolol Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest propranolol buyer importing from India?
Based on import volume and value, MILPHARM LIMITED, (UNITED KINGDOM) leads with $1.8M in imports and a 3.0% market share — the highest of any single propranolol importer. XXNEAXXPHAXXACEXXICAXX LXX (NXX (UNITED STATES) and AMNEAL PHARMACEUTICALS LLC NJ (UNITED STATES) are the next largest buyers.
QHow many companies buy propranolol from India?
There are 363 active propranolol buyers importing from India, with a combined market of $58.1M across 3,988 shipments to 99 countries. The top 5 buyers hold 9.3% of total import value, while the remaining 358 buyers handle the other 90.7%.
QWhich countries import the most propranolol from India?
The top importing countries for propranolol from India are Australia (43.9%), United States (37.5%), United Kingdom (5.5%), Canada (4.1%), Netherlands (1.8%). These markets represent the largest demand centres for Indian pharmaceutical exports of propranolol, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
The importation of Propranolol from India involves various buyer segments, each with distinct purchasing behaviors:
Distributors: Entities like MILPHARM LIMITED (United Kingdom) and APOTEX PTY LTD (Australia) function as intermediaries, procuring large quantities to supply to pharmacies and healthcare providers. Their purchasing patterns are characterized by bulk orders to maintain consistent supply chains.
Contract Manufacturers: Companies such as AMNEAL PHARMACEUTICALS LLC NJ (United States) and ACTAVIS LABORATORIES FL, INC. (United States) import Propranolol as an active pharmaceutical ingredient (API) for formulation into finished products. Their procurement is driven by production schedules and market demand forecasts.
Re-exporters: Firms like ACCORD HEALTHCARE, SLU (Spain) and BROCACEF NL : HUB (Netherlands) import Propranolol for redistribution to other markets. Their purchasing behavior is influenced by global demand trends and regulatory considerations in target countries.
Government Procurement Agencies: While not explicitly listed among the top buyers, entities such as national health services or government-affiliated organizations may engage in tender-based purchasing to supply public healthcare facilities. Their procurement processes are typically guided by budget allocations and public health priorities.
Import Registration Process: Propranolol must be listed on the Australian Register of Therapeutic Goods (ARTG). Importers must submit an application to the TGA, including evidence of product quality, safety, and efficacy.
Estimated Timeline: The registration process typically takes 6 to 12 months.
Import Tariff/Duty: Pharmaceutical products under HS Code 30049074 are generally duty-free, but Goods and Services Tax (GST) may apply.
United States:
Regulatory Authority: U.S. Food and Drug Administration (FDA).
The demand for Propranolol in importing countries is influenced by several factors:
Disease Prevalence: Propranolol is primarily used to manage cardiovascular conditions such as hypertension and arrhythmias. The global rise in cardiovascular diseases, attributed to aging populations and lifestyle changes, has increased the need for effective treatments.
Government Healthcare Programs: Many countries have implemented programs to enhance access to essential medicines. For instance, the World Health Organization (WHO) emphasizes the importance of including essential medicines like Propranolol in national formularies to ensure availability and affordability.
Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased procurement of essential medicines. Countries expanding their healthcare coverage are likely to boost demand for cost-effective treatments like Propranolol.
WHO Essential Medicines List Procurement: Propranolol's inclusion in the WHO Essential Medicines List underscores its importance in treating priority health conditions. This designation encourages countries to prioritize its procurement and distribution.
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Top Importers: United States has a diverse importer base, with their top importers including:
• XXNEAXXPHAXXACEXXICAXX LXX (NXX - $1.1M (5.2% of country's total business)
• AMNEAL PHARMACEUTICALS LLC NJ - $1.1M (5.0% of country's total business)
• ACTAVIS LABORATORIES FL, INC. - $660.5K (3.0% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $395.4K, indicating premium pricing strategy compared to the market average of $14.6K.
United States is a key market for Propranolol imports, representing 37.5% of total trade value.
Primary Market
Secondary Market
3United Kingdom
United Kingdom emerges as the third largest importing country, achieving a total trade value of $3.2M through 55 shipments. This represents a market share of 5.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United Kingdom has a diverse importer base, with their top importers including:
• MILPHARM LIMITED, - $1.8M (55.8% of country's total business)
• RELONCHEM LTD CHESHIRE HOUSE, - $559.5K (17.7% of country's total business)
• NOUMED LIFE SCIENCES LIMITED - $435.6K (13.8% of country's total business)
Key Insight: United Kingdom demonstrates strong market positioning with an average shipment value of $57.5K, indicating premium pricing strategy compared to the market average of $14.6K.
United Kingdom is a key market for Propranolol imports, representing 5.5% of total trade value.
Primary Market
Secondary Market
4Canada
Canada emerges as the fourth largest importing country, achieving a total trade value of $2.4M through 0 shipments. This represents a market share of 4.1% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Canada demonstrates strong market positioning with an average shipment value of $2.4M, indicating premium pricing strategy compared to the market average of $14.6K.
Canada is a key market for Propranolol imports, representing 4.1% of total trade value.
Primary Market
Secondary Market
5Netherlands
Netherlands emerges as the fifth largest importing country, achieving a total trade value of $1.1M through 68 shipments. This represents a market share of 1.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Netherlands has a diverse importer base, with their top importers including:
• BROCACEF NL : HUB - $441.6K (41.3% of country's total business)
• BROCACEF NL HUB BROCACEF HEALTHCAR - $202.2K (18.9% of country's total business)
Key Insight: Netherlands demonstrates strong market positioning with an average shipment value of $15.7K, indicating premium pricing strategy compared to the market average of $14.6K.
Netherlands is a key market for Propranolol imports, representing 1.8% of total trade value.
Primary Market
Secondary Market
Understanding these segments is crucial for tailoring market strategies and ensuring compliance with diverse regulatory requirements.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Import Registration Process: Importers must ensure that Propranolol complies with FDA regulations, including facility registration and product listing. A New Drug Application (NDA) or Abbreviated New Drug Application (ANDA) is required for marketing.
Estimated Timeline: The NDA/ANDA approval process can range from 10 months to several years, depending on the application type and review process.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049074 are typically duty-free.
United Kingdom:
Regulatory Authority: Medicines and Healthcare products Regulatory Agency (MHRA).
Import Registration Process: Propranolol requires a Marketing Authorisation (MA) from the MHRA. Importers must submit a dossier demonstrating compliance with UK standards.
Estimated Timeline: The MA process usually takes 210 days, excluding clock stops.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049074 are generally exempt from import duties.
Canada:
Regulatory Authority: Health Canada.
Import Registration Process: Propranolol must be approved under the Notice of Compliance (NOC) process. Importers submit a New Drug Submission (NDS) or Abbreviated New Drug Submission (ANDS) to Health Canada.
Estimated Timeline: The NDS/ANDS review process typically takes 300 days.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049074 are generally duty-free.
Import Registration Process: Propranolol requires a Marketing Authorisation from the MEB. Importers must submit a dossier in accordance with European Medicines Agency (EMA) guidelines.
Estimated Timeline: The process typically takes 210 days, excluding clock stops.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049074 are generally exempt from import duties within the EU.
Compliance with these regulations is essential for market entry and sustained operations in these countries.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Tender-Based Purchasing: Government and institutional tenders play a significant role in the procurement of pharmaceuticals. Competitive tendering processes can lead to increased orders for Propranolol, especially when aiming to meet public health objectives efficiently.
With 363 buyers across 99 countries, the global market for Propranolol presents substantial opportunities. Understanding these demand drivers is crucial for stakeholders aiming to optimize their market strategies and meet the evolving needs of healthcare systems worldwide.
TransData Nexus Research · Government and regulatory sourcesMar 2026
QWhat is the average import order value for propranolol from India?
The average import transaction value for propranolol from India is $14.6K, with an average unit price of $5.49 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Understanding these segments is crucial for tailoring market strategies and ensuring compliance with diverse regulatory requirements.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Import Registration Process: Importers must ensure that Propranolol complies with FDA regulations, including facility registration and product listing. A New Drug Application (NDA) or Abbreviated New Drug Application (ANDA) is required for marketing.
Estimated Timeline: The NDA/ANDA approval process can range from 10 months to several years, depending on the application type and review process.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049074 are typically duty-free.
United Kingdom:
Regulatory Authority: Medicines and Healthcare products Regulatory Agency (MHRA).
Import Registration Process: Propranolol requires a Marketing Authorisation (MA) from the MHRA. Importers must submit a dossier demonstrating compliance with UK standards.
Estimated Timeline: The MA process usually takes 210 days, excluding clock stops.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049074 are generally exempt from import duties.
Canada:
Regulatory Authority: Health Canada.
Import Registration Process: Propranolol must be approved under the Notice of Compliance (NOC) process. Importers submit a New Drug Submission (NDS) or Abbreviated New Drug Submission (ANDS) to Health Canada.
Estimated Timeline: The NDS/ANDS review process typically takes 300 days.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049074 are generally duty-free.
Import Registration Process: Propranolol requires a Marketing Authorisation from the MEB. Importers must submit a dossier in accordance with European Medicines Agency (EMA) guidelines.
Estimated Timeline: The process typically takes 210 days, excluding clock stops.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049074 are generally exempt from import duties within the EU.
Compliance with these regulations is essential for market entry and sustained operations in these countries.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Tender-Based Purchasing: Government and institutional tenders play a significant role in the procurement of pharmaceuticals. Competitive tendering processes can lead to increased orders for Propranolol, especially when aiming to meet public health objectives efficiently.
With 363 buyers across 99 countries, the global market for Propranolol presents substantial opportunities. Understanding these demand drivers is crucial for stakeholders aiming to optimize their market strategies and meet the evolving needs of healthcare systems worldwide.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Analysis Methodology
1.Buyer Identification: 363 global importers of Propranolol identified from consignee fields in DGFT shipping bill records.
2.Import Value Analysis: Total import value aggregated from 3,988 individual shipping bill records. Values are FOB in USD.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
4.Geographic Distribution: Buyer imports distributed across 99 destination countries with market share per buyer calculated from capped values.
